Literature DB >> 17613755

Multipotent mesenchymal stromal cells and immune tolerance.

Danièle Noël1, Farida Djouad, Carine Bouffi, Dominique Mrugala, Christian Jorgensen.   

Abstract

Multipotent mesenchymal stromal cells or mesenchymal stem cells (MSC) are isolated mainly from bone marrow and adipose tissue but are identified in other tissues such as synovium, periosteum or placenta. They are characterised by their property to adhere to plastic, their phenotype and their ability to differentiate into three lineages (chondrocytes, osteoblasts and adipocytes). More recently, these cells were shown to escape immune recognition and inhibit immune responses. MSC may modulate the function of the major immune cell populations, including antigen-presenting cells, T cells, B cells and natural killer cells. The aim of this review is to focus on the molecular mechanisms, still poorly understood, which are responsible of the immunosuppressive effects mediated by the MSC. Finally, the data obtained from in vivo experimentation in various animal models as well as potential therapeutic applications will be presented.

Mesh:

Year:  2007        PMID: 17613755     DOI: 10.1080/10428190701361869

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  35 in total

1.  Bone marrow stromal cells produce long-term pain relief in rat models of persistent pain.

Authors:  Wei Guo; Hu Wang; Shiping Zou; Ming Gu; Mineo Watanabe; Feng Wei; Ronald Dubner; George T-J Huang; Ke Ren
Journal:  Stem Cells       Date:  2011-08       Impact factor: 6.277

Review 2.  Cord blood stem cells for hematopoietic transplantation.

Authors:  Anfisa Stanevsky; Avichai Shimoni; Ronit Yerushalmi; Arnon Nagler
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

Review 3.  Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells.

Authors:  D Garbossa; M Boido; M Fontanella; C Fronda; A Ducati; A Vercelli
Journal:  Neurosurg Rev       Date:  2012-04-27       Impact factor: 3.042

4.  Clinical grade adult stem cell banking.

Authors:  Sreedhar Thirumala; W Scott Goebel; Erik J Woods
Journal:  Organogenesis       Date:  2009-07       Impact factor: 2.500

Review 5.  Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases.

Authors:  Farida Djouad; Carine Bouffi; Soufiane Ghannam; Danièle Noël; Christian Jorgensen
Journal:  Nat Rev Rheumatol       Date:  2009-07       Impact factor: 20.543

Review 6.  Fracture healing: mechanisms and interventions.

Authors:  Thomas A Einhorn; Louis C Gerstenfeld
Journal:  Nat Rev Rheumatol       Date:  2014-09-30       Impact factor: 20.543

7.  Cord blood mesenchymal stem cells suppress DC-T Cell proliferation via prostaglandin B2.

Authors:  Lieke C J van den Berk; Bas J H Jansen; Stuart Snowden; Kim G C Siebers-Vermeulen; Christian Gilissen; Gesine Kögler; Carl G Figdor; Craig E Wheelock; Ruurd Torensma
Journal:  Stem Cells Dev       Date:  2014-04-23       Impact factor: 3.272

Review 8.  The Challenge in Using Mesenchymal Stromal Cells for Recellularization of Decellularized Cartilage.

Authors:  Zhao Huang; Owen Godkin; Gundula Schulze-Tanzil
Journal:  Stem Cell Rev Rep       Date:  2017-02       Impact factor: 5.739

9.  IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis.

Authors:  Carine Bouffi; Claire Bony; Gabriel Courties; Christian Jorgensen; Danièle Noël
Journal:  PLoS One       Date:  2010-12-07       Impact factor: 3.240

Review 10.  Can mesenchymal stem cells be used to treat COVID-19-induced pneumonia? (Review).

Authors:  İdil Çetin; Mehmet Topçul
Journal:  Biomed Rep       Date:  2020-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.